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Objective: To characterize the risk factors for late-onset circulatory
collapse (LCC) in preterm infants responsive to corticosteroid therapy and
evaluate the long-term neurological prognosis.
Study Design: A retrospective case–control study for preterm infants
(p32 weeks’ gestation) admitted to our neonatal intensive care unit
from 1994 through 2002.
Result: Sixty-ﬁve infants (11%) were diagnosed with LCC. Infants with a
shorter gestation and lower birth weight had a higher incidence of LCC.
LCC infants had a signiﬁcantly lower 1-min Apgar score, signiﬁcantly
higher incidence of severe intraventricular hemorrhage, chronic lung
disease, and postnatal periventricular leukomalacia, and signiﬁcantly
longer duration of ventilation use, oxygen use, and hospital stay. Somatic
growth at 36 weeks’ postmenstrual age was poorer in infants with LCC
than without LCC (controls). LCC infants were signiﬁcantly more likely
than controls to have cerebral palsy at 3 years.
Conclusion: LCC is associated with poor neurodevelopmental outcomes.
Prevention of LCC can lead to improved neurological prognoses.
Journal of Perinatology (2010) 30, 751–756; doi:10.1038/jp.2010.41;
published online 1 April 2010
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Introduction
There have been several reports on corticosteroid-responsive
hypotension among very low birth weight (VLBW) infants during
the early postnatal period.
1–6Some reports mention the presence of
impaired adrenal function in preterm infants in the immediate
postnatal period.
7–9 However, the adrenal insufﬁciency in these
preterm infants usually returns to normal by the end of the second
week of life.
10 However, according to a recent nationwide survey in
Japan, a signiﬁcant proportion (4%) of VLBW infants may develop
corticosteroid-responsive circulatory collapse beyond the ﬁrst week
of life.
11 This study focuses on corticosteroid-responsive
hypotension among VLBW infants after the ﬁrst week of life,
referred to as late-onset circulatory collapse (LCC). Most infants
with LCC show sudden systemic hypotension and oliguria
accompanied by hyponatremia and hyperkalemia, and do not
respond to conventional treatment with a volume expander or
vasopressor-inotrope support. Corticosteroid administration
dramatically improves LCC. Recently, the adrenal insufﬁciency
associated with premature birth has been proposed as being
involved in the pathogenesis of LCC.
12,13 The objective of this study
was to describe the characteristics and neonatal complications of
infants with LCC during the hospital stay, identify its adverse
effects, and evaluate long-term neurodevelopmental outcomes.
Methods
From January 1994 to December 2002, 735 premature infants
(p32 weeks of gestation) were admitted to the neonatal intensive
care unit (NICU) at Osaka City General Hospital. As no case with
LCC was found beyond 32 weeks of gestation, infants over 32 weeks
were excluded. Among these patients, 68 had a life-threatening
congenital anomaly or chromosomal anomaly and were excluded.
In addition, 84 infants who died during the ﬁrst month were also
excluded. Among the remaining 583 preterm infants, 65 were
diagnosed with LCC and were included in this study.
Case–control study to evaluate long-term outcomes
According to our preliminary study, the gestation and birth weight
of LCC infants were signiﬁcantly lower than those in infants
without LCC (mean±s.d.; 25.4±1.7 weeks vs 28.8±2.4 weeks,
P<0.001; 776±184g vs 1209±369g, P<0.001, respectively).
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analysis of long-term outcomes of LCC, we performed a matched
1:2 case–control study by matching LCC infants with those without
LCC (control infants) whose gestational age matched within p1
week. Finally, 26 and 52 infants with and without LCC, respectively,
who were followed for at least 3 years underwent additional
analyses to determine additional risk factors for LCC.
Deﬁnition
LCC was diagnosed according to the clinical criteria for
corticosteroid treatment in our NICU. Only infants who received
corticosteroid treatment for LCC were included in our study. Four
symptoms were assessed: (1) sudden systemic hypotension (mean
arterial pressure (MAP) <35mmHg sustained for at least 3h);
(2) oliguria (<1mlkg
 1h
 1 during an 8-h interval);
(3) electrolyte abnormality (hyponatremia <130mEql
 1,
hyperkalemia >5.5mEql
 1); and (4) excess body weight gain per
day (15gkg
 1 per day or 1.5% per day). When more than two of
these symptoms were detected 7 or more days postnatally, and after
all other common conditions causing systemic hypotension and
oliguria, such as hypovolemia, dehydration, symptomatic patent
ductus arteriosus (PDA), and sepsis were ruled out, corticosteroid
treatment was started. The dose of corticosteroid was 1 to
5mgkg
 1 per dose of hydrocortisone or 0.1 to 0.2mgkg
 1 per
dose of dexamethasone. Once the infant responded to corticosteroid
therapy, LCC was diagnosed. Daily changes in body weight, MAP,
serum sodium and potassium concentrations, and urine output
before and at symptom onset were also assessed to help the
attending physician make the diagnosis of LCC.
We measured the arterial blood pressure at least every 3h by the
oscillometric technique because most infants did not have an
arterial catheter after the ﬁrst week of life. If the infant was stable,
blood pressure was measured, at minimum, once daily. If an
arterial line was present, we measured arterial blood pressure using
a pressure transducer through the catheter. A cutoff value of MAP
of 35mmHg was used to deﬁne hypotension based on an earlier
study.
14 Electrolytes were measured daily within 1 week of birth
and once weekly thereafter.
Maternal hypertension and maternal diabetes mellitus (DM) or
gestational DM (GDM) were diagnosed according to the diagnostic
criteria.
15 Premature rupture of membranes (PROM) was deﬁned
as rupture of membranes before onset of labor. Antenatal steroid
treatment was deﬁned as administration of any corticosteroid to
accelerate fetal lung maturity. Chorioamnionitis (CAM) was
diagnosed histologically by pathologists in our hospital.
Respiratory distress syndrome (RDS) was diagnosed based on
clinical and radiographic ﬁndings. PDA was diagnosed based on
the echocardiographic ﬁndings and clinical evidence of volume
overload because of a left–right shunt. Intraventricular
hemorrhage (IVH) was diagnosed according to the criteria of
Papile classiﬁcation,
16 with head ultrasound performed before
14 days of life. Necrotizing enterocolitis (NEC) was deﬁned
according to the criteria of Bell et al.
17 Gastrointestinal perforation
was diagnosed when free air was detected in the abdominal cavity
by radiograph examination.
Chronic lung disease (CLD) was deﬁned when an infant
received supplemental oxygen on the 28th day after birth, and
36-week CLD was deﬁned when an infant received supplemental
oxygen at 36 weeks’ postmenstrual age (PMA). Retinopathy of
prematurity (ROP) was deﬁned according to the International
Classiﬁcation for Retinopathy of Prematurity.
18
Periventricular leukomalacia (PVL) was deﬁned as evidence of
periventricular cysts (>3mm) on a cranial ultrasound routinely
performed on days 0, 1, 2, 7, 14, 21, 28 and more frequently
if clinically indicated until 40 weeks’ PMA. Some PVL cases were
also diagnosed with cranial computed tomography (CT) scanning
and magnetic resonance imaging (MRI) scanning at hospital
discharge by detecting ventricular dilatation, reduction in
periventricular white matter, or irregularities of the lateral
ventricular walls. To distinguish postnatal risk factors of PVL
from antenatal or perinatal ones, PVL was classiﬁed into two
groups: PVL diagnosed before 28 days was deﬁned as perinatal
PVL, whereas PVL diagnosed after 28 days was deﬁned as
postnatal PVL. All preterm infants with PVL had the diagnosis
further conﬁrmed with MRI and tests for neurodevelopmental
abnormalities at 3 years of age.
CP was deﬁned as abnormal muscle tone in at least one
extremity and abnormal control of movement and posture at
3 years of age.
Risk factors
Patient data were retrospectively collected from the hospital record.
LCC infants were compared with control patients with regard to
several variables. We assessed birth weight, gestational age, birth
weight s.d. score, male gender, patients born at other hospitals and
then transferred to our hospital, multiple births, 1- and 5-min
Apgar scores, surfactant therapy, MAP, ventilatory index, and
A-aDO2 on admission to NICU. Perinatal characteristics consisted
of maternal hypertension, maternal DM/GDM, PROM, antenatal
steroid treatment, CAM, and vaginal delivery. Neonatal
complications consisted of RDS, pulmonary hemorrhage, PDA, IVH,
and NEC/gastrointestinal perforation. Short-term prognosis
consisted of supplemental oxygen at 28 days after birth and 36
weeks’ PMA, body weight at 28 days after birth and 36 weeks’ PMA,
and total length of mechanical ventilation, O2 supplement and
hospital stay, ROP, and PVL. Long-term prognosis was evaluated by
the presence or absence of CP at 3 years.
Statistical analysis
Statistical analysis was performed using SPSS for Windows (version
17.0 SPSS, Chicago, IL, USA). Data were summarized as
mean±s.d. or median and ranges. w
2-test or Fisher’s exact test
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(95% CI) for categorical variables to test differences between infants
with or without LCC. A Mann–Whitney U test or an unpaired t-test
was used to compare continuous variables. A P-value <0.05 was
considered signiﬁcant.
Study approval
This study was approved by the internal review board of the
hospital. The study was a retrospective anonymous clinical
analysis; thus, permission from parents was waived.
Results
Overall, a total of 65 infants (11.1%) were diagnosed with LCC. The
incidence of LCC increased in accordance with lower gestational
age, occurring in 8 of 13 (61.5%) at 23 weeks’ gestation, 14 of 35
(40.0%) at 24 weeks’ gestation, 13 of 46 (28.3%) at 25 weeks’
gestation, 11 of 53 (20.8%) at 26 weeks’ gestation, 13 of 77 (16.9%)
at 27 weeks’ gestation, 5 of 57 (8.8%) at 28 weeks’ gestation, 0 of
237 (0.0%) at 29, 30, and 32 weeks’ gestation, and 1 of 65 (1.5%)
at 31 weeks’ gestation. The median number of days after birth for
LCC occurrence was 19 (range, 7 to 48 days), which corresponds to
around 29 weeks’ gestation.
Of the 65 infants with LCC, only 26 were followed over 3 years
and were included in the rest of the analyses.
Changes in body weight, MAP, serum Na and K concentrations,
and urine output
Changes in body weight, MAP, serum Na and K concentrations,
and urine output around the onset of LCC are shown in Table 1.
Each parameter signiﬁcantly changed at the onset of LCC
compared with before onset of LCC. These changes were important
factors that helped the attending physician make a diagnosis of LCC.
After corticosteroid treatment, all values returned to ﬁndings seen
before LCC onset. The median time intervals from before, onset,
and after LCC were 2 days (range, 2 to 4 days).
Basic and perinatal characteristics and incidence of neonatal
complications among LCC infants
Gestation and birth weight did not differ between LCC and control
infants (mean±s.d., 25.7±1.5 weeks vs 26.2±1.1 weeks;
741±166g vs 811±144g, respectively). Apgar score at 1min was
signiﬁcantly lower in LCC infants (median 3, range 1 to 8) than in
controls (median 5, range 1 to 8; P<0.05) (Table 2).
There were no signiﬁcant differences between perinatal
characteristics among LCC infants and controls. In terms of
neonatal complications, infants with LCC had a signiﬁcantly
higher incidence of grade X3 IVH (P<0.01).
Short- and long-term prognosis of LCC infants
LCC infants had a signiﬁcantly higher incidence of 36-week CLD
than controls (P<0.05). The length of mechanical ventilation
(P<0.05), O2 supplementation (P<0.05), and hospital stay
(P<0.01) were signiﬁcantly longer in LCC infants. In addition,
body weight at 36 weeks’ PMA was signiﬁcantly lower in LCC
infants than controls (P<0.05) (Table 3).
LCC infants had a signiﬁcantly greater incidence of
postnatal PVL than controls (P<0.01). In addition, they had a
signiﬁcantly higher incidence of CP at 3 years of age compared
with controls (P<0.001). Among LCC infants, eight were treated
with dexamethasone, but this was not a signiﬁcant factor for the
high incidence of CP (P¼0.64; OR, 1.15; 95% CI, 0.17 to 7.7).
We obtained MRI ﬁndings of six LCC infants with CP and two
controls with CP at 3 years of age. The primary ﬁndings among
these infants were four cases of reduction in periventricular
white matter, three cases of enlargement of the lateral ventricles,
Table 1 Changes in BW, MAP, serum Na and K concentrations, and urine output before LCC diagnosis, at the onset of LCC symptoms, and after LCC diagnosis
Before LCC diagnosis Onset of LCC symptoms
a After LCC diagnosis
Median
(days)
Range n Median
(days)
Range n Median
(days)
Range n
BW increase rate (%)
b 0  1  1 25 6.1±3.4
c 0 0 25 1.2±3.2
d 1+ 1 2 5
MAP (mmHg) 38.6±5.1  1  3t o 1 24 27.7±5.9
c 0 0 24 40.1±7.7
d 1+ 1 2 4
Na (mEql
 1) 133±5  3  8t o 1 26 124±8
c 0 0 26 129±7
d 2+ 1 t o + 7 2 6
K (mEql
 1) 4.3±0.5  3  8t o 1 26 5.3±0.8
c 0 0 26 4.1±0.5
d 2+ 1 t o + 7 2 6
Urine output (mlkg
 1h
 1) 4.8±1.4  1  2t o 1 24 1.5±1.6
c 0 0 25 8.1±3.7
d 1+ 1 t o + 2 2 5
Abbreviations: BW, body weight; LCC, late-onset circulatory collapse; MAP, mean arterial pressure.
aThe day of measurement of each parameter was calculated by considering the day of the onset of LCC symptoms as 0. The period between each of these intervals was measured in days.
Medians and ranges are shown.
bBW increase rate was calculated by considering the body weight before LCC diagnosis as standard.
cP<0.05 compared with before LCC diagnosis.
dP<0.05 compared with onset of LCC symptoms.
Data are represented as mean±s.d.
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Journal of Perinatologythree cases of thinning of the corpus callosum, three cases of
cerebellum atrophy, and two cases of irregularities of the lateral
ventricular walls.
Discussion
In the past several years, patients with sudden cardiac dysfunction
after the ﬁrst week of life, such as systemic hypotension and
oliguria accompanied by hyponatremia and hyperkalemia, have
been shown to dramatically improve with corticosteroid
administration. These pathological conditions, which are clearly
different from the unstable circulatory status observed in the acute
phase of premature babies soon after birth, have been recently
deﬁned as LCC in Japan.
With the independent diagnostic criteria of LCC in our hospital,
we found that about 11% of preterm infants at p32 weeks’
gestation were diagnosed with LCC. Birth weight and gestational
ages of LCC infants were signiﬁcantly lower than those without
LCC. The occurrence of LCC was higher with smaller gestational
ages, and in addition to hypotension and oliguria, LCC infants
showed abnormal serum electrolyte changes. These results indicate
that prematurity is one of the most important characteristics of
LCC, and we speculate that adrenal insufﬁciency may explain this
presentation.
12,13
In this analysis, we performed a 1:2 case–control study by
matching LCC infants with controls whose gestational age
differed by p1 week to help eliminate the role of prematurity
in LCC. This study is unique because for the ﬁrst time we
Table 2 Basic and perinatal characteristics and incidence of neonatal complications among infants with LCC
Characteristic LCC (n¼26) Controls (n¼52) P-value OR 95% CI
Basic characteristic
Birth weight (g), mean±s.d. 741±166 811±144 NS FF
Gestational age (weeks), mean ±s.d. 25.7±1.5 26.2±1.1 NS FF
Birth weight s.d. score, mean ±s.d.  0.48±0.78  0.39±0.70 NS FF
Male gender 13 (50%) 23 (44%) NS 0.79 0.31–2.04
Outborn
a 4 (15%) 5 (10%) NS 1.71 0.42–7.00
Multiple birth 7 (27%) 19 (37%) NS 0.64 0.23–1.80
Apgar score
At 1min, median (range) 3 (1–8) 5 (1–8) <0.05 FF
At 5min, median (range) 6 (2–9) 6 (2–9) NS FF
Surfactant given 20 (77%) 35 (67%) NS 1.62 0.55–4.77
On admitting NICU
Mean arterial presssure, mean ±s.d. 24.2±5.5 26.8±6.2 NS FF
Ventilatory index, mean ±s.d. 0.08±0.06 0.06±0.04 NS FF
A-aDO2, mean ±s.d. 382±178 330±197 NS FF
Perinatal characteristic
Maternal hypertension 2 (8%) 6 (12%) NS 0.64 0.12–3.41
Maternal DM/GDM 0 (0%) 0 (0%) NS FF
PROM 11 (42%) 29 (56%) NS 0.58 0.23–1.51
Received antenatal steroid 8 (31%) 16 (31%) NS 1.00 0.36–2.77
CAM 17 (65%) 29 (56%) NS 1.50 0.57–3.98
Cesarean section 17 (65%) 38 (73%) NS 0.70 0.25–1.92
Neonatal complications
RDS 12 (46%) 21 (40%) NS 1.27 0.49–3.27
Pulmonary hemorrhage 4 (15%) 5 (10%) NS 1.71 0.42–6.99
PDA 7 (27%) 19 (37%) NS 0.64 0.23–1.80
IVH
Grade 1–2 6 (23%) 11 (21%) NS 1.12 0.36–3.46
Grade X3 5 (19%) 0 (0%) <0.01 1.23 1.03–1.49
NEC/gastrointestinal perforation 1 (4%) 0 (0%) NS 1.04 0.96–1.12
Abbreviations: A-aDO2, alveolar-arterial oxygen tension difference; CAM, chorioamnionitis diagnosed histologically; CI, conﬁdence interval; DM, diabetes mellitus; GDM, gestational
diabetes mellitus; IVH, intraventricular hemorrhage; LCC, late-onset circulatory collapse; NEC, necrotizing enterocolitis; NICU, neonatal intensive care unit; OR, odds ratio; PDA, patent
ductus arteriosus; PROM, premature rupture of membranes; RDS, respiratory distress syndrome.
aOutborn refers to infants born in other hospitals and transferred to our hospital.
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Journal of Perinatologydetermined the long-term prognosis of LCC infants, who
experienced a signiﬁcantly greater incidence of CP at 3 years of age
compared with control infants. In addition, according to our
results, LCC infants had a higher incidence of severe IVH and CLD
at 36 weeks’ PMA, and poorer neurological prognosis such as
postnatal PVL.
As previously reported, premature infants have a decreased
capacity to synthesize cortisol, which may lead to a relative adrenal
insufﬁciency and signiﬁcant illness.
19–21 It is conceivable that the
pathogenesis of LCC correlates with the adrenal function of preterm
infants,
12 and the high incidence of CLD in LCC infants in this
study is consistent with these reports.
Both prenatal and postnatal pathophysiologic mechanisms can
induce PVL.
22–26 A postnatal form of cystic PVL has been previously
reported among eight cases detected by ultrasound between 16 days
and 10 weeks after birth.
27 Another report described a postnatal
form of cystic PVL appearing beyond the ﬁrst 5 weeks of life in a
large population of preterm infants born before 33 weeks.
28
Recently, Kobayashi et al.
29 performed a small case–case control
study of preterm infants (p32 weeks’ gestation) and demonstrated
a signiﬁcant association between late-onset PVL and late-onset
circulatory dysfunction among these infants. As there is no
treatment for PVL, it is important to stabilize the cerebral
circulation, especially between the 28th and 32nd weeks of
gestation, during which LCC was most prevalent in this study.
In addition, LCC should be treated immediately to prevent
postnatal PVL.
This study showed that LCC infants had a signiﬁcantly greater
chance of developing CP at 3 years of age. As the dose of steroid
therapy used to treat LCC was within the physiological range, it is
unlikely that poor neurological outcome occurred from excess use
of steroid therapy.
30,31 Moreover, contrary to the use of
dexamethasone, hydrocortisone administration (early or late) may
not be associated with an increased incidence of CP. The high
incidence of severe IVH (19%) and postnatal PVL (27%) in LCC
infants might be correlated with the high incidence of CP.
However, considering that 73% of LCC infants developed CP, it is
possible that LCC may independently contribute to CP. On the other
hand, in this study, diffuse PVL might have been missed by the
routine ultrasonography because early MRI or CT was not done. In
addition, MRI at discharge was not routinely performed, and MRI
at 3 years of age was only performed on study group patients with
CP. Thus, more LCC infants might have developed PVL, and that
might be the reason for the high rate of CP in LCC infants.
This study has several limitations. Among the 735 infants
admitted to our NICU, only 212 patients (26 LCC infants and 186
controls) were followed until 3 years of age because of lack of
clinical records. This large attrition of records makes it difﬁcult to
set up a population-based study to determine the risk factors for
long-term prognosis of LCC. In addition, this was a single-center
Table 3 Short- and long-term prognosis of infants with LCC compared with controls
Prognosis LCC (n¼26) Controls (n¼52) P-value OR 95% CI
Short-term prognosis
CLD
Oxygen at 28 days 26 (100%) 50 (96%) NS 0.96 0.91–1.02
Oxygen at 36 weeks 20 (77%) 25 (48%) <0.05 3.60 1.25–10.41
Body weight at 28 days 734±180 807±162 NS FF
Body weight at 36 weeks 1233±379 1424±285 <0.05 FF
Days of ventilation, median (range) 31 (2–150) 18 (2–89) <0.05 FF
Days of oxygen, median (range) 100 (40–357) 78 (5–290) <0.05 FF
Hospital stay, median (range) 153 (87–359) 129 (77–291) <0.01 FF
PVL
Perinatal PVL 1 (4%) 1 (2%) NS 1.00 0.12–8.09
Postnatal PVL 7 (27%) 2 (4%) <0.01 9.21 1.76–48.34
ROP
Stages 1–2 10 (38%) 16 (31%) NS 1.41 0.53–3.77
XStage 3 16 (62%) 36 (69%) NS 0.71 0.27–1.91
Long-term prognosis
CP 19 (73%) 10 (19%) <0.001 11.40 3.77–34.51
Abbreviations: CI, conﬁdence interval; CLD, chronic lung disease; CP, cerebral palsy; LCC, late-onset circulatory collapse; OR, odds ratio; PVL, periventricular leukomalacia;
ROP, retinopathy of prematurity.
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and the other causative risk factors to other populations. Another
weakness of this study was that because serum cortisol levels and
stimulation tests were not performed, we could not directly
determine the correlation between LCC and adrenal insufﬁciency.
LCC, which occurs at the most vulnerable time for white matter
injury, may be an important risk factor for PVL and CP, and its
development may identify a more vulnerable patient population. As
there are no curative therapies for PVL and CP, LCC should be
rapidly diagnosed and treated. A multicenter, large-scale study is
warranted to elucidate the pathogenesis of LCC and its correlation
with poor neurological development.
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